Bank Of New York Mellon Corp Selecta Biosciences Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.96 - $1.6 $346,342 - $577,236	360,773 New	360,773 $407,000
Q3 2022 Nov 14, 2022	BUY	$1.33 - $2.6 $48,499 - $94,811	36,466 Added 97.22%	73,974 $121,000
Q2 2022 Aug 15, 2022	SELL	$0.67 - $1.4 $167,871 - $350,775	-250,554 Reduced 86.98%	37,508 $49,000
Q1 2022 May 11, 2022	SELL	$1.23 - $3.31 $8,169 - $21,985	-6,642 Reduced 2.25%	288,062 $354,000
Q4 2021 Feb 11, 2022	BUY	$2.89 - $4.43 $21,492 - $32,945	7,437 Added 2.59%	294,704 $961,000
Q3 2021 Nov 12, 2021	BUY	$3.36 - $4.62 $100,581 - $138,299	29,935 Added 11.63%	287,267 $1.2 Million
Q2 2021 Aug 11, 2021	BUY	$2.82 - $5.01 $170,688 - $303,245	60,528 Added 30.76%	257,332 $1.08 Million
Q1 2021 May 13, 2021	SELL	$2.92 - $5.07 $66,497 - $115,459	-22,773 Reduced 10.37%	196,804 $891,000
Q4 2020 Feb 09, 2021	BUY	$1.64 - $3.42 $23,962 - $49,969	14,611 Added 7.13%	219,577 $665,000
Q3 2020 Nov 12, 2020	BUY	$2.18 - $2.84 $43,652 - $56,868	20,024 Added 10.83%	204,966 $508,000
Q2 2020 Aug 12, 2020	BUY	$1.83 - $4.06 $338,443 - $750,864	184,942 New	184,942 $525,000
Q2 2019 Aug 12, 2019	SELL	$1.79 - $3.05 $154,119 - $262,605	-86,100 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$1.47 - $3.06 $50,394 - $104,902	34,282 Added 66.16%	86,100 $204,000
Q4 2018 Feb 11, 2019	BUY	$2.66 - $15.93 $420 - $2,516	158 Added 0.31%	51,818 $138,000
Q3 2018 Nov 09, 2018	BUY	$12.07 - $16.0 $52,951 - $70,192	4,387 Added 9.28%	51,660 $0
Q2 2018 Aug 06, 2018	BUY	$9.36 - $13.25 $94,667 - $134,010	10,114 Added 27.22%	47,273 $626,000
Q1 2018 May 15, 2018	SELL	$8.49 - $11.82 $373 - $520	-44 Reduced 0.12%	37,159 $379,000
Q4 2017 Feb 09, 2018	BUY	$8.97 - $23.38 $333,710 - $869,806	37,203	37,203 $365,000

Others Institutions Holding SELB

# of Institutions

Shares Held

4.67M

Call Options Held

Put Options Held

View Full List

About SELECTA BIOSCIENCES INC

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

More about SELB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account